T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus
August 09, 2022 08:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Reports Granting of Inducement Awards
July 29, 2022 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards...
T2 Biosystems to Report Second Quarter 2022 Financial Results on August 15, 2022
July 28, 2022 16:32 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference
July 27, 2022 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel
July 11, 2022 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the...
T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results
July 06, 2022 08:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems to Appear on the Benzinga All Access Show on June 17, 2022
June 15, 2022 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market
June 10, 2022 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease
May 20, 2022 09:17 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the...
T2 Biosystems Announces First Quarter 2022 Financial Results
May 05, 2022 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...